User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

Association between ABO blood group and fibrosis severity in chronic hepatitis C infection.

Primary tabs

Poujol-Robert, Armelle Boëlle, Pierre-Yves Wendum, Dominique Poupon, Raoul Robert, Annie [UCL]

The progression of fibrosis in hepatitis C virus (HCV) infection is a process in which genes interact with environmental factors. A "clotting process" is involved in fibrogenesis. ABO blood group distribution is associated with thrombotic disease, non-O blood group increasing the risk of venous thrombosis. The aim of the study was to investigate whether ABO blood type contributes to the severity of fibrosis. We studied blood group distribution in 346 French patients with HCV infection who underwent biopsies. The distribution of non-O blood group was 40%, 55%, 62%, 71%, and 73% for the F0, F1, F2, F3 and F4 fibrosis scores, respectively. Non-O blood group was associated with increased severity of fibrosis, even after adjustment on gender, age, duration of infection, and alcohol consumption (odds ratio 1.8, 95% confidence interval 1.0-2.9; P=.04). Non-O blood group is an independent risk factor for the progression of liver fibrosis in HCV infection.

Document type Article de périodique (Journal article) – Comparative Study, Journal Article
Access type Accès restreint
Publication date 2006
Journal information "Digestive diseases and sciences" - Vol. 51, no. 9, p. 1633-6 (2006)
Peer reviewed yes
issn 0163-2116
Publication status Publié
Affiliation UCL - MD/ESP - Ecole de santé publique
MESH Subject ABO Blood-Group System ; Adult ; Disease Progression ; Female ; Hepacivirus - isolation & purification ; Hepatitis C, Chronic - blood - pathology ; Humans ; Liver Cirrhosis - blood - pathology ; Liver Function Tests ; Male ; Middle Aged ; Prevalence ; Risk Factors ; Severity of Illness Index
Links
  1. Seeff LB (2002) Natural history of chronic hepatitis C. Hepatology 36 (Suppl 1):S35–46
  2. Papatheodoridis GV, Papakonstantinou E, Andrioti E, Cholongitas E, Petraki K, Kontopoulou I, Hadziyannis SJ (2003) Thrombotic risk factors and extent of liver fibrosis in chronic viral hepatitis. Gut 52:404–409
  3. Poujol-Robert A, Rosmorduc O, Serfaty L, Coulet F, Poupon R, Robert A (2004) Genetic and acquired thrombotic factors in chronic hepatitis C. Am J Gastroenterol 99:527–531
  4. Wright M, Goldin R, Hellier S, Knapp S, Frodsham A, Hennig B, Hill A, Apple R, Cheng S, Thomas H, Thursz M (2003) Factor V Leiden polymorphism and the rate of fibrosis development in chronic hepatitis C virus infection. Gut 52:1206–1210
  5. Poujol-Robert A, Boëlle PY, Poupon R, Robert A (2004) Activated protein C resistance (factor V Leiden) as a risk factor for cirrhosis in chronic hepatitis C patients. Hepatology 39:1174–1175
  6. Jick H, Slone D, Westerholm B, Inman WH, Vessey MP, Shapiro S, Lewis GP, Worcester J (1969) Venous thromboembolic disease and ABO blood group type. A cooperative study. Lancet 1:539–542
  7. Koster T, Blann AD, Briet E, Vandenbroucke JP, Rosendaal FR (1995) Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis. Lancet 345:152–154
  8. Robert A, Aillaud MF, Eschwege V, Randrianjohany A, Scarabin Y, Juhan-Vague I (2000) ABO blood group and risk of venous thrombosis in heterozygous carriers of factor V Leiden. Thromb Haemostasis 83:630–631
  9. The French Metavir Cooperative Study Group (1994) Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. Hepatology 20:15–20
  10. Agresti A (1996) An introduction to categorical data analysis. John Wiley & Sons, New York
  11. Harrell Frank E., Regression Modeling Strategies, ISBN:9781441929181, 10.1007/978-1-4757-3462-1
  12. Anstee QM, Wright M, Goldin R,et al. (2004) The factor V Leiden mutation accelerates disease progression in a mouse model of hepatic fibrosis induced by chronic carbon tetrachloride exposure. Hepatology 40;534A
  13. Marra F, Grandaliano G, Valente AJ, Abboud HE (1995) Thrombin stimulates proliferation of liver fat-storing cells and expression of monocytes chemotactic protein-1: potential role in liver injury. Hepatology 22:780–787
  14. Wanless IR, Wong F, Blendis LM, Greig P, Heathcote EJ, Levy G (1995) Hepatic and portal vein thrombosis in cirrhosis: Possible role in development of parenchymal extinction and portal hypertension. Hepatology 21:1238–1247
  15. Goodman ZD, Ishak KG (1982) Occlusive venous lesions in alcoholic liver disease. Gastroenterology 83:786–796
  16. Gill JC, Endres-Brooks J, Bauer PJ, Marks WJ Jr, Montgomery RR (1987) The effect of ABO blood group on the diagnosis of von Willebrand disease. Blood 69:1691–1695
  17. Kraaijenhagen RA, in’t Anker PS, Koopman MM, Reitsma PH, Prins MH, van den Ende A, Buller HR (2000) High plasma concentration of factor VIIIc is a major risk factor for venous thromboembolism. Thromb Haemost 83:5–9
  18. Kamphuisen P. W., Eikenboom J. C. J., Bertina R. M., Elevated Factor VIII Levels and the Risk of Thrombosis, 10.1161/01.atv.21.5.731
Bibliographic reference Poujol-Robert, Armelle ; Boëlle, Pierre-Yves ; Wendum, Dominique ; Poupon, Raoul ; Robert, Annie. Association between ABO blood group and fibrosis severity in chronic hepatitis C infection.. In: Digestive diseases and sciences, Vol. 51, no. 9, p. 1633-6 (2006)
Permanent URL http://hdl.handle.net/2078.1/25822